Medibank share price resilient as class action law suit hits

The Medibank share price has managed a positive move this morning despite news on legal action regarding the October data breach.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The Medibank share price has moved back into positive territory in morning trade
  • The ASX 200 health insurer is facing a class action lawsuit in relation to October's massive data breach
  • Law firm Maurice Blackburn has lodged a representative complaint with the Office of the Australian Information Commission

The Medibank Private Ltd (ASX: MPL) share price is edging higher in morning trade, up 0.8% after opening 0.2% lower.

Shares in the S&P/ASX 200 Index (ASX: XJO) healthcare stock, Australia's largest health insurer, closed yesterday trading for $2.97. Medibank shares are currently trading for $3 apiece.

While that's no huge lift, the Medibank share price has managed a positive move this morning. That's despite what looks to be the commencement of a class action lawsuit in regard to the massive 12 October data breach.

A boy stands in still ankle-deep water brandishing a bow and arrow.

Image source: Getty Images

As a quick recap, in October Russian-linked cybercriminals accessed the names, dates of birth, addresses, phone numbers and email addresses of 9.7 million current and former Medibank customers. They also hacked into the health claims data for some 480,000 customers.

The Medibank share price fell more than 20% over the following weeks in the wake of the cyberattack. The health insurer did not pay the ransom demands, and much of the stolen data was published on the dark web.

This morning the company reported that class action lawyers from Maurice Blackburn have lodged a representative complaint with the Office of the Australian Information Commission (OAIC).

Medibank said that the OAIC has not yet been in contact about the complaint.

"The complaint includes allegations that Medibank has breached the Australian Privacy Principles and seeks compensation for individuals whose personal information was exposed as a consequence of the cybercrime," the health insurer stated.

Medibank said it will continue to support its customers with the impact of the cybercrime through its previously announced Cyber Response Support Program. That program includes "mental health and wellbeing support, identity protection and financial hardship measures".

The company also reiterated that it will continue to cooperate with the OAIC in this ongoing investigation.

Medibank share price snapshot

The Medibank share price remains down 15% since October's massive data breach was revealed. As you can see in the chart below, shares are now down 13% year to date.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A cool white-bearded man holds his hand up signalling you should halt.
Healthcare Shares

ASX 300 cannabis stock Incannex suspended ahead of 'material update'

The Incannex share price is frozen at 14 cents for now.

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

Guess which ASX All Ords stock is rocketing 27% on a new FDA approval

Rett Syndrome has finally got an approved treatment.

Read more »

Five healthcare workers standing together and smiling.
Healthcare Shares

Buy these excellent ASX 200 healthcare shares: Goldman Sachs

Goldman has spoken very positively about these healthcare shares this week.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
Healthcare Shares

Should I buy CSL shares while they're under $300?

Can investors make a healthy return with this biotech?

Read more »

A man wearing a white coat holds his hands up and mouth open with joy.
Healthcare Shares

Mesoblast share price rockets 23% on FDA news

Mesoblast has received some good news for the US FDA this morning.

Read more »

A young woman wearing a blue blouse with white polkadots holds her phone up with an intrigued and happy look on her face as she reads some news.
Healthcare Shares

Owners of this ASX 200 share are soon going to receive a bigger dividend

Investors in this healthcare company are about to get a healthy cash boost.

Read more »

an older couple look happy as they sit at a laptop computer in their home.
Healthcare Shares

Hoping to collect the latest CSL dividend? Here's how

The next CSL dividend is fast approaching.

Read more »